These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22669921)

  • 1. Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure.
    Wallace MC; James AL; Marshall M; Kontorinis N
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22669921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation.
    Benítez C; Arrese M; Jorquera J; Godoy I; Contreras A; Loyola S; Domínguez P; Jarufe N; Martínez J; Pérez-Ayuso RM
    Ann Hepatol; 2009; 8(1):71-4. PubMed ID: 19221539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatopulmonary syndrome.
    Koch DG; Fallon MB
    Clin Liver Dis; 2014 May; 18(2):407-20. PubMed ID: 24679503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Transjugular Intrahepatic Portosystemic Shunts in the Management of Hepatopulmonary Syndrome: A Systemic Literature Review.
    Tsauo J; Weng N; Ma H; Jiang M; Zhao H; Li X
    J Vasc Interv Radiol; 2015 Sep; 26(9):1266-71. PubMed ID: 26074026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Transjugular Intrahepatic Portosystemic Shunt Creation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: A Prospective Study.
    Tsauo J; Zhao H; Zhang X; Ma H; Jiang M; Weng N; Li X
    J Vasc Interv Radiol; 2019 Feb; 30(2):170-177. PubMed ID: 30717947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome.
    Lasch HM; Fried MW; Zacks SL; Odell P; Johnson MW; Gerber DA; Sandhu FS; Fair JH; Shrestha R
    Liver Transpl; 2001 Feb; 7(2):147-9. PubMed ID: 11172400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome.
    Zhao H; Liu F; Yue Z; Wang L; Fan Z; He F
    Medicine (Baltimore); 2017 Dec; 96(49):e9080. PubMed ID: 29245324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
    Therapondos G; Wong F
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease.
    Boike JR; Flamm SL
    Clin Liver Dis; 2020 Aug; 24(3):373-388. PubMed ID: 32620278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt.
    Nistal MW; Pace A; Klose H; Benten D; Lohse AW
    Thorax; 2013 Sep; 68(9):889-90. PubMed ID: 22382598
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.
    Martinez-Palli G; Drake BB; Garcia-Pagan JC; Barbera JA; Arguedas MR; Rodriguez-Roisin R; Bosch J; Fallon MB
    World J Gastroenterol; 2005 Nov; 11(43):6858-62. PubMed ID: 16425397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.
    Tatah JH; Weir EK; Prins KW; Thenappan T
    Chest; 2021 Apr; 159(4):e193-e196. PubMed ID: 34022017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
    Liu MH; Zhou F; Wang XB; Chen LP; Li GZ; Zhao Q
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):596-600. PubMed ID: 30317791
    [No Abstract]   [Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial.
    Rosemurgy AS; Serafini FM; Zweibel BR; Black TJ; Kudryk BT; Nord HJ; Goode SE
    J Gastrointest Surg; 2000; 4(6):589-97. PubMed ID: 11307093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature.
    Paramesh AS; Husain SZ; Shneider B; Guller J; Tokat I; Gondolesi GE; Moyer S; Emre S
    Pediatr Transplant; 2003 Apr; 7(2):157-62. PubMed ID: 12654059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year follow-up.
    Chevallier P; Novelli L; Motamedi JP; Hastier P; Brunner P; Bruneton JN
    J Vasc Interv Radiol; 2004 Jun; 15(6):647-8. PubMed ID: 15178729
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.